Abingdon Health Plc (LON:ABDX – Get Free Report) was down 2.2% on Wednesday . The stock traded as low as GBX 11 and last traded at GBX 11. Approximately 8,378 shares changed hands during trading, a decline of 97% from the average session volume of 303,568 shares. The stock had previously closed at GBX 11.25.
Abingdon Health Stock Performance
The firm has a market capitalization of £27.62 million, a PE ratio of -13.58 and a beta of 0.18. The business has a 50-day simple moving average of GBX 11.24 and a 200-day simple moving average of GBX 8.40. The company has a debt-to-equity ratio of 15.05, a current ratio of 1.91 and a quick ratio of 1.96.
About Abingdon Health
Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval. The Company also markets its own range of self-tests under the Abingdon Simply Test brand (www.abingdonsimplytest.com) and has developed and marketed its own labelled tests.
Featured Articles
- Five stocks we like better than Abingdon Health
- Why KB Home Could Reward Patient Investors Later
- Meta’s Internal Turmoil: Morale Nears 20-Year Low at the Wrong Time
- Tesla’s New NHTSA Probe Lands at the Worst Possible Time
- Nano Nuclear’s AI Data Center Deal Puts the Stock Back in Focus
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
